In vivo pharmacological evaluation of a lactose-conjugated luteinizing hormone releasing hormone analogue.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International journal of pharmaceutics

• Publication date

  2015-11-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2015.08.095PMID 26325323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Holland-Frei Cancer Medicine

  2016cited by this paper
• A Drug Delivery Strategy: Binding Enkephalin to Asialoglycoprotein Receptor by Enzymatic Galactosylation

  2014cited by this paper
• The transport and efflux of glycosylated luteinising hormone-releasing hormone analogues in caco-2 cell model: contributions of glucose transporters and efflux systems.

  2014cited by this paper
• Development of a methodology for and assessment of pulsatile luteinizing hormone secretion in juvenile and adult male mice.

  2013cited by this paper
• Synthesis and in vitro evaluation of glycosyl derivatives of luteinizing hormone-releasing hormone (LHRH).

  2013cited by this paper
• Synthesis and biological evaluation of an orally active glycosylated endomorphin-1.

  2012cited by this paper
• Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.

  2012influential reference
• Modern lipid‐, carbohydrate‐, and peptide‐based delivery systems for peptide, vaccine, and gene products

  2011cited by this paper
• Mass spectrometry for small molecule pharmaceutical product development: a review.

  2011cited by this paper
• Emerging gonadotropin-releasing hormone agonists

  2011cited by this paper
• Validation of an LC/MS method for the determination of gemfibrozil in human plasma and its application to a pharmacokinetic study.

  2010cited by this paper
• Chemoenzymatic synthesis of glycosylated glucagon-like peptide 1: effect of glycosylation on proteolytic resistance and in vivo blood glucose-lowering activity.

  2009cited by this paper
• Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists.

  2009cited by this paper
• In vivo evaluation and in vitro metabolism of leuprolide in mice--mass spectrometry-based biomarker measurement for efficacy and toxicity.

  2008cited by this paper
• Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the caco-2 cell monolayer system.

  2006cited by this paper
• Strategies to improve plasma half life time of peptide and protein drugs

  2006cited by this paper
• GnRH analogues--agonists and antagonists.

  2005cited by this paper
• Triptorelin in the Treatment of Prostate Cancer

  2005cited by this paper
• Gonadotropin-releasing hormone receptors.

  2004cited by this paper
• Pharmacokinetics of triptorelin after intravenous bolus administration in healthy males and in males with renal or hepatic insufficiency.

  2003cited by this paper
• Progress in liquid chromatography-mass spectrometry instrumentation and its impact on high-throughput screening.

  2003cited by this paper
• LC/MS applications in drug development.

  2002cited by this paper
• Gonadotropin-releasing-hormone-receptor antagonists.

  2001cited by this paper
• Glycopeptide Synthesis and the Effects of Glycosylation on Protein Structure and Activity

  2000cited by this paper
• Improved bioavailability to the brain of glycosylated Met-enkephalin analogs.

  2000cited by this paper
• Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.

  1996cited by this paper
• Peptide Stability in Drug Development. II. Effect of Single Amino Acid Substitution and Glycosylation on Peptide Reactivity in Human Serum

  1993cited by this paper
• Pharmacokinetics of gonadotropin-releasing hormone and its analogs.

  1986influential reference
• Metabolic clearance and plasma half-disappearance time of D-TRP6 and exogenous luteinizing hormone-releasing hormone.

  1982cited by this paper
• Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function.

  1981cited by this paper
• ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE WITH INCREASED BIOLOGICAL ACTIVITY PRODUCED BY D-AMINO ACID SUBSTITUTIONS IN POSITION 6

  1976cited by this paper
• Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by D-amino acid substitutions in position 6.

  1976cited by this paper
• The half-life, metabolism and excretion of tritiated luteinizing hormone-releasing hormone (LH-RH) in man.

  1973influential reference
• Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies.

  1971cited by this paper
• Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence.

  1971cited by this paper

• Computational avenues in oral protein and peptide therapeutics.

  2021cites this paper
• Gonadotropin Releasing Hormone and GnRH Receptor: Structure, Function and Drug Development.

  2019cites this paper
• Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides

  2016cites this paper
• Recent advances in oral delivery of peptide hormones

  2016cites this paper
• Gonadotropin releasing hormone

  2014cites this paper